These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1964577)

  • 1. Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure.
    Gibelin P; Sbirrazzuoli V; Drici M; Camous JP; Lapalus P; Morand P
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1105-11. PubMed ID: 1964577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
    Martin C; Viviand X; Arnaud S; Vialet R; Rougnon T
    Crit Care Med; 1999 Sep; 27(9):1708-13. PubMed ID: 10507587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
    Abraham WT; Lowes BD; White M; Ferguson DA; Scheffel CA; Wolfel EE; Lindenfeld J; Bristow MR
    J Card Fail; 1994 Oct; 1(1):57-62. PubMed ID: 9420633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.
    Nagata K; Iwase M; Sobue T; Yokota M
    J Am Coll Cardiol; 1995 Feb; 25(2):295-304. PubMed ID: 7829780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.
    Adamopoulos S; Piepoli M; Qiang F; Pissimissis E; Davies M; Bernardi L; Forfar C; Sleight P; Coats A
    Lancet; 1995 Feb; 345(8946):344-9. PubMed ID: 7845114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure.
    Al-Hesayen A; Azevedo ER; Newton GE; Parker JD
    J Am Coll Cardiol; 2002 Apr; 39(8):1269-74. PubMed ID: 11955843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of beta-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure.
    Teng JK; Kwan CM; Lin LJ; Tsai LM; Cheng JT; Chang WC; Chen JH
    Eur Heart J; 1993 Oct; 14(10):1349-53. PubMed ID: 8262081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):391-8. PubMed ID: 1520649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
    Colucci WS; Leatherman GF; Ludmer PL; Gauthier DF
    Circ Res; 1987 Oct; 61(4 Pt 2):I82-6. PubMed ID: 3652407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic changes, plasma catecholamine responses, and echocardiographically detected contractile reserve during two different dobutamine-infusion protocols.
    Poldermans D; Boersma E; Fioretti PM; Cornel JH; Sciarra A; Salustri A; Boomsma F; Roelandt JR; Man in 't Veld AJ
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):808-13. PubMed ID: 9234663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
    Colucci WS; Denniss AR; Leatherman GF; Quigg RJ; Ludmer PL; Marsh JD; Gauthier DF
    J Clin Invest; 1988 Apr; 81(4):1103-10. PubMed ID: 2832444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
    Bersin RM; Wolfe C; Kwasman M; Lau D; Klinski C; Tanaka K; Khorrami P; Henderson GN; de Marco T; Chatterjee K
    J Am Coll Cardiol; 1994 Jun; 23(7):1617-24. PubMed ID: 8195522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does dobutamine prevent the rise in left ventricular filling pressures observed during exercise after heart transplantation?
    Vantrimpont PJ; Felice H; Paulus WJ
    Eur Heart J; 1995 Sep; 16(9):1300-6. PubMed ID: 8582395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.
    Merlet P; Dubois-Randé JL; Adnot S; Bourguignon MH; Benvenuti C; Loisance D; Valette H; Castaigne A; Syrota A
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):10-6. PubMed ID: 1375674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.